Revolymer PLC REVO Board Appointment

  Revolymer PLC (REVO) - Board Appointment

RNS Number : 1296M
Revolymer PLC
13 September 2012

                                Revolymer plc

                         ("Revolymer" or "the Group")

               Dr Bryan C Dobson to Join the Board of Revolymer


 Former Croda International Plc ("Croda") executive to become an Independent
                            Non-Executive Director

Revolymer (AIM: REVO), the British  polymer company developing products for  a 
number of high value fast moving  consumer goods ("FMCG") markets, is  pleased 
to announce with immediate effect the appointment of Dr Bryan Crawford  Dobson 
to the Board of Directors as an independent non-executive director. Dr  Dobson 
will also chair the Remuneration Committee.

Dr Dobson has 33  years' experience in the  chemicals industry; 28 years  with 
ICI and 5 years with Croda, and was most recently President Global  Operations 
for Croda. He was a member of the executive management teams in Croda and in a
number of  large speciality  chemicals  businesses in  ICI and  has  extensive 
management experience running regional  and global business  units in the  UK, 
US, Belgium  and The  Netherlands. He  also has  expertise in  developing  new 
business in speciality chemicals  sectors; extensive functional experience  in 
R&D and operations and significant M&A experience.

Dr Dobson, commenting on his appointment said, "I am excited to be joining the
Board of Revolymer and look forward to playing an active role in assisting the
commercial and technical  development of  the Group, which  has an  attractive 
technology portfolio."

Jack Keenan, Chairman  of Revolymer commenting  on today's announcement  said, 
"Bryan's decision to join the Board of Revolymer is yet another endorsement of
the Group's technology and commercial  strategy. His commercial and  technical 
knowledge and expertise in  both chemicals and  FMCG markets complements  well 
the skill base around the board table and will be instrumental in the  further 
development of the Group's business."

Dr Dobson (aged 59) holds or  has held the following directorships within  the 
last 5 years:

Current                                                Previous
The Newcastle upon Tyne Hospitals NHS Foundation Trust Uniqema Nederland BV
Durham Graphene Science Ltd                            

Save as set out above, there is  no information specified by paragraph (g)  in 
Schedule Two to the AIM Rules that is required to be disclosed.



For further information please contact:

Revolymer plc                                             +44 (0) 1244 283 500
Roger Pettman                                             

Rob Cridland
Panmure Gordon (UK) Limited                               +44 (0) 20 7886 2500
Callum Stewart / Adam James (Corporate Finance)           

Adam  Pollock   /  Charles   Leigh-Pemberton   (Corporate 
Citigate Dewe Rogerson                                    +44 (0)20 7638 9571
Simon Rigby / David Dible / Ginny Pulbrook                

About Revolymer

Revolymer is a technology company that designs, develops and formulates  novel 
polymers to improve the performance  of existing consumer products within  the 
FMCG markets.  Revolymer's strategy  is to  generate significant  and  growing 
revenue streams  by  licensing  its unique  and  proprietary  technologies  to 
manufacturers and  marketers  within  the global  high  value  FMCG  industry. 
Current applications for  the Group's  technologies are  in the  confectionery 
chewing gum  and  medicated  chewing  gum (together  "gum")  markets;  and  in 
coatings & adhesives, household products and personal care (together "consumer

                     This information is provided by RNS
           The company news service from the London Stock Exchange


BOALTMITMBTBBTT -0- Sep/13/2012 06:01 GMT
Press spacebar to pause and continue. Press esc to stop.